Headlines

Merck held talks to buy biotech MoonLake for over $3 billion, FT reports

Published by Global Banking & Finance Review

Posted on June 2, 2025

1 min read

· Last updated: January 23, 2026

Add as preferred source on Google
Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter. (

Merck in Talks to Acquire Swiss Biotech MoonLake for Over $3 Billion

(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shounak Dasgupta)

Key Takeaways

  • Merck is negotiating to acquire MoonLake Immunotherapeutics.
  • The deal is valued at over $3 billion.
  • MoonLake is a Swiss biotech company.
  • The report comes from the Financial Times.
  • This acquisition highlights Merck's expansion strategy.

Frequently Asked Questions

What company is Merck in talks to acquire?
Merck is in discussions to buy Swiss biotech MoonLake Immunotherapeutics.
How much is Merck reportedly willing to pay for MoonLake?
Merck has held talks to acquire MoonLake for more than $3 billion.
Which publication reported on Merck's acquisition talks?
The Financial Times reported on the talks between Merck and MoonLake.

Tags

Related Articles

More from Headlines

Explore more articles in the Headlines category